Letters to Congress
Recent letters sent by the U.S. Chamber to members of Congress, communicating the opinion of the business community on pending legislation.
Latest
This letter was sent to Chairman Brady and the members of the Committee on Ways and Means expressing the Chamber’s commitment to comprehensive tax reform.
This letter was sent to the members of the House Subcommittee on Health opposing any amendments that may be offered to the Food and Drug Administration Reauthorization Act of 2017 that would allow the importation of foreign pharmaceuticals into the United States or that would undermine the preemptive authority of federal food and drug regulations. The Subcommittee is marking up the bill tomorrow morning. May 17, 2017
This letter was sent to the Chairman Tim Walberg and Ranking Member Gregorio Kilili Camacho Sablan of the House Subcommittee on Health, Employment, Labor, and Pensions in advance of the Subcommittee’s hearing entitled “Regulatory Barriers Facing Workers and Families Saving for Retirement.” The letter expresses the Chamber’s support for policies that encourage employment based retirement saving plans and investment in individual retirement accounts and outlines the Chamber’s policy recommendations – all of which can be found in greater detai
On May 16, 2017,he Chamber sent a letter to Senator Johnson and Senator McCaskill offering our support for S. 584, the Small Business Regulatory Flexibility Improvements Act.
Dear Chairman Johnson and Ranking Member McCaskill, The U.S. Chamber of Commerce urges the Committee to favorably report S. 951, the “Regulatory Accountability Act of 2017,” which was introduced by Senators Portman and Heitkamp and would make long-overdue improvements to the federal regulatory process. Enactment of the Regulatory Accountability Act (RAA) is a long-standing, top priority for the Chamber.
On May 16, the Chamber submitted these written comments to the Department of Treasury in response to Executive Order 13789 issued on April 21, 2017.
This letter was sent to the members of the Senate Committee on Health, Education, Labor, and Pensions opposing amendments that may be offered to S. 934, the Food and Drug Administration Reauthorization Act, that would allow the importation of foreign pharmaceuticals into the United States or that would undermine the preemptive authority of federal food and drug regulations. May 9, 2017
TO THE MEMBERS OF THE UNITED STATES SENATE: The U.S. Chamber of Commerce urges you to support H.J. Res. 36, which would undo the Bureau of Land Management’s rule related to methane production. The Chamber will consider including votes on or related to this legislation in our annual How They Voted scorecard.